Delivering unique monoclonal antibodies of extreme specificity

SYnAbs' mission is to generate innovative antibodies against poor immunogenic compounds and complex antigens. 

 

Either as a custom service,

or as a catalog product,

you can benefit

from SYnAbs technologies

to get access to 

unique monoclonal antibodies.

 




In SYnAbs they trust


The benefits of SYnAbs technologies?

  1. Extreme specificity monoclonal antibodies
  2. Higher affinity monoclonal antibodies
  3. Excellent results for small, difficult and poor immunogenic antigens
  4. Additional epitope recognition
  5. High and stable producer clones
  6. Access to multiple immune repertoires
  7. Raising antibodies against difficult to express antigens
  8. Generating antibodies against conformation sensitive targets


SYnAbs 2019 agenda

February 1st

Feb 4th - Feb 5th

Feb 21st - Feb 22nd

March 11th - March 13th

April 2nd - April 5th

May 9th

May 21st - May 23rd

June 18th - June 19th 

Aug 3rd - Aug 8th

Sep 10th - Sep 11th

Sep 10th - Sep 12th

Oct 15th - Oct 17th

Nov 18th - Nov 21rst

Nov 12th - Nov 16th

Dec 10th - Dec 11th 

Antwerpen, Belgium, BACR

Toulouse, France, Buzz4Bio mAb production

Leuven, Belgium, Life-on-chip

Alpach, Austria, The Alpach Workwhop

Vienna, Austria, BioProcess International

Ghent, Belgium, Knowledge for Growth

Hannover, Germany, Labvolution/Biotechnica

Oxford, United Kingdom, Pivotal Scientific

Anaheim, USA, AACC

Leuven, Belgium, Cellular heterogeneity in CNS

Copenhagen, Denmark, Nordic Life Science Days

Bale, Switzerland, Antibody European Congress

Dusseldorf, Germany, MEDICA

Lisbon, Portugal, PEGS

Marseille, France, Biofit